
Moberg Pharma Investor Relations Material
Latest events

Q4 2024
Moberg Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Moberg Pharma
Access all reports
Moberg Pharma AB develops, manufactures and markets OTC products in the areas of footcare and oral healthcare. The company own the rights to a patented platform technology, which means that they can tailor each product exactly to the needs of each customer. The products are primarily sold through intermediaries and are developed in close collaboration with leading retailers, who sell them on their home markets. Moberg Pharma AB market some of their products directly under their own brands, or via the company's own sales force on a limited number of selected markets.
Key slides for Moberg Pharma


Q4 2024
Moberg Pharma


Q4 2024
Moberg Pharma
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
MOB
Country
🇸🇪 Sweden